Lupin Introduces Azilsartan Medoxomil Tablets in the United States
Lupin Limited (Lupin) the Indian Global pharmaceuticals major announced that the company will launch Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States, which got approval from the U.S. byAbbreviated New Drug Application (ANDA).
This is a bioequivalent product of Edarbi® produces byAzurity Pharmaceuticals,...
Health Ministry Bans 16 Fixed Dose Combination Drugs to Safeguard Public Health
In a major move to protect public health, the Union Ministry of Health and Family Welfare has banned the manufacture, sale, and distribution of...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
Eli Lilly Acquires 4E Therapeutics to Accelerate Development of Non-Opioid Chronic Pain Treatments
Eli Lilly and Company (Lilly) has successfully acquired 4E Therapeutics, a Texas-based neuroscience company pioneering next-generation treatments for chronic pain. The acquisition integrates 4E...
Pfizer Announces CFO Transition as Dave Denton Exits Company
On 18th June Pfizer Inc. (NYSE: PFE) the American Pharmaceuticals major announced that Dave Denton currently working as Chief Financial Officer (CFO) will step down from his current role and leave the company on...
